Dnase treatment in primary ciliary dyskinesia assessment by nocturnal pulse oximetry

Pediatric Pulmonology

Volumn 27, Issue 1, 1999, Pages 59-61

  Ten Berge, Maartje ^a   Brinkhorst, Govert ^a   Kroon, André A ^a   De Jongste, Johan C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Body plethysmography; DNase; Primary ciliary dyskinesia; Pulse oximetry

Indexed keywords

DEOXYRIBONUCLEASE;

ARTICLE; BODY PLETHYSMOGRAPH; CASE REPORT; CHILD; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DRUG EFFECT; HUMAN; MALE; PRIORITY JOURNAL; PULSE OXIMETRY;

ADMINISTRATION, INHALATION; CILIARY MOTILITY DISORDERS; CIRCADIAN RHYTHM; DEOXYRIBONUCLEASE I; EXPECTORANTS; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; OXIMETRY; RECOMBINANT PROTEINS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME;

EID: 0032895065     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199901)27:1<59::AID-PPUL11>3.0.CO;2-D     Document Type: Article

References (12)

1. Lethem MI, James SL, Marriott C, Burke JF. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990;3:19-23.
2. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase 1 reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990;87:9188-9192.
3. Zahm JM, Girod de Bentzmann S, Deneuville E, Perrot-Minnot C, Dabadie A, Pennaforte F, Roussey M, Shak S, Puchelle E. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus. Eur Respir J 1995;8:381-386.
4. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group [see comments]. N Engl J Med 1994;331:637-642.
5. Afzelius BA. A human syndrome caused by immotile cilia. Science 1976;193:317-319.
6. Afzelius BA. The immotile-cilia syndrome and other ciliary diseases. Int Rev Exp Pathol 1979;19:1-43.
7. Stocks J, Marchal F, Kraemer R. Gutkowski P, Bar Yishay E, Godfrey S. Plethysmographic assessment of functional residual capacity and airway resistance. In: Stocks J, Sly P, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: Wiley-Liss, Inc.; 1996. p 191-239.
8. Desai M, Weller PH, Spencer DA. Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome. Pediatr Pulmonol 1995;20:307-308.
9. Gershan WM, Rusakow LS, Chetty A, Splaingard ML. Resolution of chronic atelectasis in a child with asthma after aerosolized recombinant human DNase [Letter]. Pediatr Pulmonol 1994;18: 268-269.
10. Greally P. Human recombinant DNase for mucus plugging in status asthmaticus [Letter]. Lancet 1995;346:1423-1424.
11. Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993;147:1132-1137.
12. Potter JL, Spector S, Matthews LW, Lemm J. Studies on pulmonary secretions. 3. The nucleic acids in whole pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis 1969;99:909-916.